Task: Answer the multiple choice question.
Query: Which drug exhibits a -23.117% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a.) c1ccc(Nc2nc3ccccc3n3cnnc23)cc1
b.) COc1cc([C@H]2[C@@H]3CCCC[C@]3(O)CCN2CC(=O)Nc2ccc(C)cc2)ccc1O
c.) O=C(Nc1c(F)cccc1F)c1cnc(N2CCN(c3ccccn3)CC2)c2ccccc12
d.) COc1ccc(NC(=O)CSc2ccc(-c3ccccn3)nn2)cc1OC
e.) Cc1cc(C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(C)o1
Answer: d. COc1ccc(NC(=O)CSc2ccc(-c3ccccn3)nn2)cc1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(NC(=O)CSc2ccc(-c3ccccn3)nn2)cc1OC
COc1ccc(NC(=O)CSc2ccc(-c3ccccn3)nn2)cc1OC
N-(3,4-dimethoxyphenyl)-2-(6-pyridin-2-ylpyridazin-3-yl)sulfanylacetamide